Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Cena, Hellas ^a   Tesone, Antonella ^a   Niniano, Rosanna ^b   Cerveri, Isa ^b   Roggi, Carla ^a   Turconi, Giovanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Insulin resistance; Metabolic syndrome; Overweight; Smoking habit; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84878221247     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-28     Document Type: Article

References (47)

1. Tobacco free initiative: Why is tobacco a public health priority. World Health Organization, Available at: http://www.who.int/tobacco/health-priority/ en/ Accessed on January 31, 2011 8718429
2. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. Targher G, Alberiche M, Zenere MB, et al. J Clin Endocrinol Metab 1997 82 3619 3624 10.1210/jc.82.11.3619 9360516 (Pubitemid 27509346)
3. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Wada T, Urashima M, Fukumoto T, Intern Med 2007 46 1079 1082 10.2169/internalmedicine.46.0026 17634703 (Pubitemid 47354462)
4. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Lee WY, Jung CH, Park JS, et al. Diabetes Res Clin Pract 2005 67 70 77 10.1016/j.diabres.2004.05.006 15620436 (Pubitemid 40037732)
5. Influence of smoking on predictors of vascular disease. Tsiara S, Elisaf M, Mikhailidis DP, Angiology 2003 54 507 530 10.1177/000331970305400501 14565627 (Pubitemid 37175529)
6. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Steiner G, Schwartz L, Shumak S, et al. Circulation 1987 75 124 130 10.1161/01.CIR.75.1.124 3791598 (Pubitemid 17234549)
7. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Criqui MH, Wallace RB, Heiss G, et al. Circulation 1980 62 V70 IV76 7418146
8. Relationship between smoking and Metabolic Syndrome. Cena H, Fonte ML, Turconi G, Nutr Rev 2011 69 12 745 753 10.1111/j.1753-4887.2011.00446.x 22133198
9. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Miyatake N, Wada J, Kawasaki Y, et al. Intern Med 2006 45 1039 1043 10.2169/internalmedicine.45.1850 17043374 (Pubitemid 44613582)
10. The metabolic syndrome in smokers. The D.E.S.I.R. study. Geslain-Biquez C, Vol S, Tichet J, et al. Diabetes Metab 2003 29 226 234 10.1016/S1262-3636(07) 70031-9 12909810 (Pubitemid 36813979)
11. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Weitzman M, Cook S, Auinger P, et al. Circulation 2005 112 862 869 10.1161/CIRCULATIONAHA.104.520650 16061737 (Pubitemid 41170073)
12. Association of smoking in adolescence with abdominal obesity in adulthood: a follow-up study of 5 birth cohorts of Finnish twins. Saarni SE, Pietilainen K, Kantonen S, et al. Am J Public Health 2009 99 348 354 10.2105/AJPH.2007.123851 19059868
13. Association of smoking status, insulin resistance, body mass index, and metabolic syndrome in workers: a 1-year follow-up study. Kawada T, Otsuka T, Inagaki H, et al. Obes Res Clin Pract 2010 4 163 e169 10.1016/j.orcp.2009.12.004
14. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? Reaven G, Tsao PS, J Am Coll Cardiol 2003 41 1044 1047 10.1016/S0735-1097(02)02982-0 12651055 (Pubitemid 36315551)
15. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Durnin JV, Womersley J, Br J Nutr 1974 32 1 77 97 10.1079/BJN19740060 4843734
16. Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography-based Assessment. Li Y, Swensen SJ, Karabekmez LG, et al. Cancer Prev Res 2011 4 1 43 50 10.1158/1940-6207.CAPR-10-0151
17. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. Forey BA, Thornton AJ, Lee PN, BMC Pulm Med 2011 11 36 10.1186/1471-2466-11-36 21672193
18. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Assmann G, Guerra R, Fox G, et al. Am J Cardiol 2007 99 541 548 10.1016/j.amjcard.2006.08.045 17293200 (Pubitemid 46215539)
19. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Alberti KG, Eckel RH, Grundy SM, National Heart, Lung, and Blood Institute, et al. Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
20. Shaw Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Alberti KG, Zimmet P, J Diabetes Med 2006 23 5 469 480 10.1111/j.1464-5491.2006.01858.x
21. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Ford ES, Li C, Zhao G, J Diabetes 2010 2 3 180 193 10.1111/j.1753-0407.2010.00078.x 20923483
22. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, et al. Circulation 2005 112 17 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
23. Lifecourse predictors of normal metabolic parameters in overweight and obese adults. Hayes L, Pearce MS, Unwin NC, Int J Obes 2006 30 6 970 976 10.1038/sj.ijo.0803213 (Pubitemid 43801198)
24. Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes. Wannamethee SG, Shaper AG, Whincup PH, J Am Geriatr Soc 2006 54 12 1909 1914 10.1111/j.1532-5415.2006.00974.x 17198498 (Pubitemid 44915836)
25. Lifestyle Behaviors associeted with lower risk of having the Metabolic Syndrome. Zhu S, St-Onge MP, Heshka S, et al. Metabolism 2004 53 11 1503 1511 10.1016/j.metabol.2004.04.017 15536610 (Pubitemid 39410395)
26. Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work. Pinto Pereira SM, Ki M, Power C, PLoS One 2012 7 2 31132 10.1371/journal.pone.0031132 22347441
27. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Tankó LB, Christiansen C, Menopause 2004 11 1 104 109 10.1097/01.GME.0000079740.18541.DB 14716190 (Pubitemid 40362206)
28. Body fat distribution in relation to smoking and exogenous hormones in British women. Kwok S, Canoy D, Soran H, et al. Clin Endocrinol 2011 10.1111/j.1365-2265.2011.04331.x
29. Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based survey. Clair C, Chiolero A, Faeh D, et al. BMC Public Health 2011 11 23 10.1186/1471-2458- 11-23 21223575
30. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Chiolero A, Faeh D, Paccaud F, et al. Am J Clin Nutr 2008 87 4 801 809 18400700 (Pubitemid 351549222)
31. Studies in the distribution of body fat. Effects of cigarettes smoking. Shimokata H, Muller DC, Andres R, JAMA 1989 26 1169 1173 (Pubitemid 19062452)
32. Visceral adiposity as a target for the management of the metabolic syndrome. Kishida K, Funahashi T, Matsuzawa Y, et al. Ann Med 2011 44 3 233 241 21612331
33. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. Petursson H, Sigurdsson JA, Bengtsson C, et al. PLoS One 2011 6 10 26621 10.1371/journal.pone.0026621 22028926
34. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Will JC, Galuska DA, Ford ES, et al. Int J Epidemiol 2001 30 3 540 546 10.1093/ije/30.3.540 11416080 (Pubitemid 32600247)
35. Novel association between bioaviable estradiol and adipokines in ederlywomen with different phenotypes of obesity: implication for atherogenesis. Tanko LB, Circulation 2004 110 15 2246 2252 10.1161/01.CIR.0000144470.55149.E5 15451790 (Pubitemid 39372509)
36. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. Cryer PE, Haymond MW, Santiago JV, et al. N Engl J Med 1976 295 11 573 577 10.1056/NEJM197609092951101 950972
37. Cigarettes, coronary occlusion, and myocardial infarction. Kannel WB, JAMA 1981 246 8 871 872 10.1001/jama.1981.03320080057033 7253166 (Pubitemid 11043085)
38. Metabolic syndrome: a work in progress, but a useful construct. Beaser RS, Levy P, Circulation 2007 115 1812 1818 10.1161/CIRCULATIONAHA.106.673616 17404172
39. The insulin resistance syndrome in smokers is related to smoking habits. Eliasson B, Attvall S, Taskinen MR, et al. Arterioscler Thromb 1994 14 12 1946 1950 10.1161/01.ATV.14.12.1946 7981184
40. Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. Barter P, Atheroscler Suppl 2011 12 3 265 266 10.1016/S1567-5688(11)00035-3 22272435
41. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Kontush A, Chapman MJ, Nat Clin Pract Cardiovasc Med 2006 3 3 144 153 10.1038/ncpcardio0500 16505860
42. European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies. Graham I, Atar D, Borch-Johnsen K, et al. Eur J Cardiovasc Prev Rehabil 2007 14 Suppl. 2 1 S113 18091132
43. Review et ESC/EAS Guidelines for the management of dyslipidaemias. Alberico L, The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Authors/Task Force Members, et al. Atherosclerosis 2011 217S 1 S44
44. Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Travier N, Agudo A, May A, et al. Prev Med 2012 54 3-4 183 192 21939684
45. Relationship among phisycal activity, smoking, drinking and clustering of the Metabolic Syndrome Diagnostic Components. Katano S, Nakamura Y, Nakamura A, et al. J Atheroscler Thromb 2010 17 6 644 650 10.5551/jat.3699 20379052
46. Effects of smoking cessation on body composition in postmenopausal women. Kleppinger A, Litt MD, Kenny AM, et al. J Womens Health 2010 19 9 1651 1657 10.1089/jwh.2009.1853
47. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Gorber SC, Tremblay M, Moher D, et al. Obes Rev 2007 8 4 307 326 10.1111/j.1467-789X.2007.00347.x 17578381 (Pubitemid 46944496)